🇺🇸 FDA
Pipeline program

Recombinant human growth hormone (r-hGH)

27709

Approved small_molecule completed

Quick answer

Recombinant human growth hormone (r-hGH) for Dwarfism, Pituitary is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Dwarfism, Pituitary
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials